KalVista Pharmaceuticals, Inc. (KALV)
26.84
+0.08
(+0.28%)
USD |
NASDAQ |
May 29, 11:20
KalVista Pharmaceuticals EPS Diluted (Quarterly) : -0.4303 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8121 |
| Sensei Biotherapeutics, Inc. | -3.622 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.49M |
| Revenue (Quarterly) | 40.86M |
| Total Expenses (Quarterly) | 64.35M |
| Enterprise Value | 1.425B |
| Gross Profit Margin (Quarterly) | 91.57% |
| Profit Margin (Quarterly) | -57.48% |
| Earnings Yield | -9.60% |
| Normalized Earnings Yield | -9.509 |